Small Molecule CMO and CDMO Market Analysis, Demand, and Growth Rate Forecast 2035
According to Payal Rabde, who specializes in small molecule drug development and manufacturing, API manufacturing solutions, Contract research and manufacturing services, and end-to-end manufacturing services, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the small molecule CMO and CDMO market. The global small molecule CMO and CDMO market size was estimated at USD 75.8 billion in 2025 and is predicted to increase from USD 79.7 billion in 2026 to approximately USD 125.13 billion by 2035, expanding at a CAGR of 5.14% from 2026 to 2035. His analysis highlights the increasing adoption of cost-effective production services, pharmaceutical outsourcing partnerships, contract manufacturing outsourcing services, and flexible manufacturing capabilities. The research also examines the competitive strategies of key industry participants, including Lonza, Cambrex, Recipharm, Thermo Fisher Scientific Inc., and Euroapi, shaping the future by flexible manufacturing capabilities, strengthening global supply chains, scalable manufacturing solutions, and cost-effective drug manufacturing in the global small molecule CMO and CDMO market.
Last Updated : 22 September 2026
Category: Healthcare Services
Insight Code: 6716
Format: PDF / PPT / Excel